Could a simple blood test replace biopsies for prostate cancer?
NCT ID NCT06604130
First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 3 times
Summary
This study is testing a new blood test that looks at RNA from tiny particles called exosomes to diagnose prostate cancer. Researchers will enroll 1,600 men with elevated PSA levels or other signs of prostate cancer. The goal is to see if this test can accurately detect cancer and reduce the need for invasive biopsies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Plasma exosome RNA panel (diagnostic test)
- What this could lead to
- If successful, this could provide a more accurate, non-invasive blood test for prostate cancer, reducing unnecessary biopsies.
- What could go wrong
- This is an early diagnostic study, not a treatment trial. The test may not prove more accurate than existing methods, and results may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Yan'an University,
Yan’an, Shaanxi, 716000, China
-
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, 750000, China
-
Qinghai University Affiliated Hospital
Xining, Qinghai, 810000, China
-
Shaanxi Provincial People's Hospital
Xi'an, Shaanxi, 710000, China
-
The First Hospital of Lanzhou University
Lanzhou, Gansu, 730000, China
-
The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
Xianyang, Shaanxi, 712000, China
-
Weinan Central Hospital
Weinan, Shaanxi, 714000, China
-
Xijing 986 Hospital
Xi'an, Shaanxi, 710000, China
-
Xijing Hospital
Xi'an, Shaanxi, 710032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?